316 related articles for article (PubMed ID: 30640172)
1. HSP90 inhibitor geldanamycin reverts IL-13- and IL-17-induced airway goblet cell metaplasia.
Pezzulo AA; Tudas RA; Stewart CG; Buonfiglio LGV; Lindsay BD; Taft PJ; Gansemer ND; Zabner J
J Clin Invest; 2019 Feb; 129(2):744-758. PubMed ID: 30640172
[TBL] [Abstract][Full Text] [Related]
2. HSP90 inhibitors strengthen extracellular ATP-stimulated synthesis of interleukin-6 in osteoblasts: Amplification of p38 MAP kinase.
Hioki T; Tokuda H; Nakashima D; Fujita K; Kawabata T; Sakai G; Kim W; Tachi J; Tanabe K; Matsushima-Nishiwaki R; Otsuka T; Iida H; Kozawa O
Cell Biochem Funct; 2021 Jan; 39(1):88-97. PubMed ID: 32567086
[TBL] [Abstract][Full Text] [Related]
3. Distinct regulation of insulin receptor substrate-1 and -2 by 90-kDa heat-shock protein in adrenal chromaffin cells.
Yoshikawa N; Nemoto T; Satoh S; Maruta T; Yanagita T; Chosa E; Wada A
Neurochem Int; 2010 Jan; 56(1):42-50. PubMed ID: 19737590
[TBL] [Abstract][Full Text] [Related]
4. Hsp90 inhibitor geldanamycin attenuates the cytotoxicity of sunitinib in cardiomyocytes via inhibition of the autophagy pathway.
Kimura T; Uesugi M; Takase K; Miyamoto N; Sawada K
Toxicol Appl Pharmacol; 2017 Aug; 329():282-292. PubMed ID: 28624441
[TBL] [Abstract][Full Text] [Related]
5. HSP90 inhibitors potentiate PGF2α-induced IL-6 synthesis via p38 MAP kinase in osteoblasts.
Fujita K; Tokuda H; Kuroyanagi G; Yamamoto N; Kainuma S; Kawabata T; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
PLoS One; 2017; 12(5):e0177878. PubMed ID: 28542188
[TBL] [Abstract][Full Text] [Related]
6. Aldose reductase inhibition prevents metaplasia of airway epithelial cells.
Yadav UC; Aguilera-Aguirre L; Ramana KV; Boldogh I; Srivastava SK
PLoS One; 2010 Dec; 5(12):e14440. PubMed ID: 21203431
[TBL] [Abstract][Full Text] [Related]
7. Non-benzoquinone geldanamycin analogs trigger various forms of death in human breast cancer cells.
Zhang Z; Li HM; Zhou C; Li Q; Ma L; Zhang Z; Sun Y; Wang L; Zhang X; Zhu B; Hong YS; Wu CZ; Liu H
J Exp Clin Cancer Res; 2016 Sep; 35(1):149. PubMed ID: 27658586
[TBL] [Abstract][Full Text] [Related]
8. Absence of proteinase-activated receptor-1 signaling in mice confers protection from fMLP-induced goblet cell metaplasia.
Atzori L; Lucattelli M; Scotton CJ; Laurent GJ; Bartalesi B; De Cunto G; Lunghi B; Chambers RC; Lungarella G
Am J Respir Cell Mol Biol; 2009 Dec; 41(6):680-7. PubMed ID: 19307611
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of RPE cell sterile inflammatory responses and endotoxin-induced uveitis by a cell-impermeable HSP90 inhibitor.
Qin S; Ni M; Wang X; Maurier-Mahé F; Shurland DL; Rodrigues GA
Exp Eye Res; 2011 Dec; 93(6):889-97. PubMed ID: 22019372
[TBL] [Abstract][Full Text] [Related]
10. Epithelial miR-141 regulates IL-13-induced airway mucus production.
Siddiqui S; Johansson K; Joo A; Bonser LR; Koh KD; Le Tonqueze O; Bolourchi S; Bautista RA; Zlock L; Roth TL; Marson A; Bhakta NR; Ansel KM; Finkbeiner WE; Erle DJ; Woodruff PG
JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33682796
[TBL] [Abstract][Full Text] [Related]
11. Heat shock protein 90 (Hsp90) regulates the stability of transforming growth factor beta-activated kinase 1 (TAK1) in interleukin-1beta-induced cell signaling.
Shi L; Zhang Z; Fang S; Xu J; Liu J; Shen J; Fang F; Luo L; Yin Z
Mol Immunol; 2009 Feb; 46(4):541-50. PubMed ID: 18950863
[TBL] [Abstract][Full Text] [Related]
12. Elimination of IL-13 reverses established goblet cell metaplasia into ciliated epithelia in airway epithelial cell culture.
Kondo M; Tamaoki J; Takeyama K; Isono K; Kawatani K; Izumo T; Nagai A
Allergol Int; 2006 Sep; 55(3):329-36. PubMed ID: 17075276
[TBL] [Abstract][Full Text] [Related]
13. The FOXM1 inhibitor RCM-1 suppresses goblet cell metaplasia and prevents IL-13 and STAT6 signaling in allergen-exposed mice.
Sun L; Ren X; Wang IC; Pradhan A; Zhang Y; Flood HM; Han B; Whitsett JA; Kalin TV; Kalinichenko VV
Sci Signal; 2017 Apr; 10(475):. PubMed ID: 28420758
[TBL] [Abstract][Full Text] [Related]
14. 17-DMCHAG, a new geldanamycin derivative, inhibits prostate cancer cells through Hsp90 inhibition and survivin downregulation.
Wang J; Li Z; Lin Z; Zhao B; Wang Y; Peng R; Wang M; Lu C; Shi G; Shen Y
Cancer Lett; 2015 Jun; 362(1):83-96. PubMed ID: 25813406
[TBL] [Abstract][Full Text] [Related]
15. The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation.
Schnaider T; Somogyi J; Csermely P; Szamel M
Cell Stress Chaperones; 2000 Jan; 5(1):52-61. PubMed ID: 10701840
[TBL] [Abstract][Full Text] [Related]
16. Notch2 is required for inflammatory cytokine-driven goblet cell metaplasia in the lung.
Danahay H; Pessotti AD; Coote J; Montgomery BE; Xia D; Wilson A; Yang H; Wang Z; Bevan L; Thomas C; Petit S; London A; LeMotte P; Doelemeyer A; Vélez-Reyes GL; Bernasconi P; Fryer CJ; Edwards M; Capodieci P; Chen A; Hild M; Jaffe AB
Cell Rep; 2015 Jan; 10(2):239-52. PubMed ID: 25558064
[TBL] [Abstract][Full Text] [Related]
17. Geldanamycin interferes with the 90-kDa heat shock protein, affecting lipopolysaccharide-mediated interleukin-1 expression and apoptosis within macrophages.
Hsu HY; Wu HL; Tan SK; Li VP; Wang WT; Hsu J; Cheng CH
Mol Pharmacol; 2007 Jan; 71(1):344-56. PubMed ID: 16868182
[TBL] [Abstract][Full Text] [Related]
18. Suppression of the mTOR-raptor signaling pathway by the inhibitor of heat shock protein 90 geldanamycin.
Ohji G; Hidayat S; Nakashima A; Tokunaga C; Oshiro N; Yoshino K; Yokono K; Kikkawa U; Yonezawa K
J Biochem; 2006 Jan; 139(1):129-35. PubMed ID: 16428328
[TBL] [Abstract][Full Text] [Related]
19. Geldanamycin, an inhibitor of heat shock protein 90 (Hsp90) mediated signal transduction has anti-inflammatory effects and interacts with glucocorticoid receptor in vivo.
Bucci M; Roviezzo F; Cicala C; Sessa WC; Cirino G
Br J Pharmacol; 2000 Sep; 131(1):13-6. PubMed ID: 10960063
[TBL] [Abstract][Full Text] [Related]
20. [Effect of geldanamycin on the expression of signal proteins and heat shock proteins in normal mice lymphocytes].
Novoselova TV; Cherenkov DA; Khrenov MO; Glushkova OV; Lunin SM; Novoselova EG; Fesenko EE
Tsitologiia; 2008; 50(7):629-35. PubMed ID: 18771179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
